Molecular Tests - G2 Intelligence

NCI Program Expands Access to Key Diagnostic for Childhood Cancers

by Rachel Muenz | Mar 28, 2022 | Articles, News, Open Content

A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system tumors....

New Assay Could ID Best Cancer Treatment Earlier and Faster

by Rachel Muenz | Feb 14, 2022 | Articles, News, Open Content

A recently developed assay could make identifying the best cancer treatment for each patient a quicker and more cost-effective process, compared to current tests. Researchers from the Public Health Research Institute of the New Jersey Medical School of Rutgers...

COVID-19 Fuels Massive & Sustainable Growth in Molecular Diagnostics

by Glenn S. Demby | Aug 7, 2020 | Articles, Essential, Laboratory Industry Report, Top of the News-lir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

Medicare Reimbursement: CMS Begins Implementing New HOPPS Date of Service Rules for ADLTs & Molecular Pathology Tests

by Glenn S. Demby | Aug 13, 2018 | Essential, National Lab Reporter, News-nir, Reimbursement-nir

From - National Intelligence Report
CMS has begun implementing the new rules that exempt advanced diagnostic laboratory tests (ADLTs) and molecular pathology tests from…

. . . read more